Associations of gamma-glutamyl transferase with cardio-metabolic diseases in people living with HIV infection in South Africa.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
08
2020
accepted:
13
01
2021
entrez:
5
2
2021
pubmed:
6
2
2021
medline:
24
7
2021
Statut:
epublish
Résumé
Gamma-glutamyl transferase (GGT) has recently been reported as a biomarker for cardiovascular (CVD) risk in general populations. We investigated the associations of GGT with cardio-metabolic diseases and CVD risk in South Africans living with HIV. In this cross-sectional study, HIV-infected adults were randomly recruited across 17 HIV clinics in the Western Cape Province. Homeostatic model assessment for insulin resistance (HOMA-IR), hypertension, diabetes, metabolic syndrome by Joint Interim Statement criteria (JIS-MS), a ≥5% and ≥10% predicted risk for a CVD event within 10 years by the Framingham risk score (10-years-CVD risk) were computed. Associations between GGT and cardio-metabolic trait were explored using linear and binomial logistic regressions adjusted for age, gender, lifestyle behaviours and HIV-related characteristics. Among 709 participants (561 women, mean age 38.6 years), log-GGT was positively associated with waist circumference (β=2.75; p<0.001), diastolic blood pressure (β=1.65; p=0.006), total cholesterol (β=0.21; p<0.001), low-density lipoprotein-cholesterol (β=0.16; p<0.001), high-density lipoprotein-cholesterol and log-triglycerides (both β=0.12; p<0.001), fasting plasma glucose (β=0.19; p=0.031), 2-hour-post-glucose-load plasma glucose (β=0.26; p=0.007), HOMA-IR (β=0.13; p=0.001), log-high-sensitivity C-reactive-protein (β=0.3; p<0.001) in linear regression analyses; with hypertension [OR=1.41 (95%CI, 1.13-1.75); p=0.001], JIS-MS [OR=1.33 (1.05-1.68); p=0.016], ≥5% 10-year-CVD risk [OR=1.55 (1.24-1.9400); p<0.001] and ≥10% 10-year-CVD risk [OR=1.56 (1.08-2.23); p=0.016] but not with diabetes [OR=1.24 (0.88-1.71), p=0.205] in logistic regression analyses. In this study, GGT levels were associated with cardio-metabolic variables independent of HIV specific attributes. If confirmed in longitudinal studies, GGT evaluation maybe included in CVD risk monitoring strategies in people living with HIV.
Sections du résumé
BACKGROUND
Gamma-glutamyl transferase (GGT) has recently been reported as a biomarker for cardiovascular (CVD) risk in general populations. We investigated the associations of GGT with cardio-metabolic diseases and CVD risk in South Africans living with HIV.
METHODS
In this cross-sectional study, HIV-infected adults were randomly recruited across 17 HIV clinics in the Western Cape Province. Homeostatic model assessment for insulin resistance (HOMA-IR), hypertension, diabetes, metabolic syndrome by Joint Interim Statement criteria (JIS-MS), a ≥5% and ≥10% predicted risk for a CVD event within 10 years by the Framingham risk score (10-years-CVD risk) were computed. Associations between GGT and cardio-metabolic trait were explored using linear and binomial logistic regressions adjusted for age, gender, lifestyle behaviours and HIV-related characteristics.
RESULTS
Among 709 participants (561 women, mean age 38.6 years), log-GGT was positively associated with waist circumference (β=2.75; p<0.001), diastolic blood pressure (β=1.65; p=0.006), total cholesterol (β=0.21; p<0.001), low-density lipoprotein-cholesterol (β=0.16; p<0.001), high-density lipoprotein-cholesterol and log-triglycerides (both β=0.12; p<0.001), fasting plasma glucose (β=0.19; p=0.031), 2-hour-post-glucose-load plasma glucose (β=0.26; p=0.007), HOMA-IR (β=0.13; p=0.001), log-high-sensitivity C-reactive-protein (β=0.3; p<0.001) in linear regression analyses; with hypertension [OR=1.41 (95%CI, 1.13-1.75); p=0.001], JIS-MS [OR=1.33 (1.05-1.68); p=0.016], ≥5% 10-year-CVD risk [OR=1.55 (1.24-1.9400); p<0.001] and ≥10% 10-year-CVD risk [OR=1.56 (1.08-2.23); p=0.016] but not with diabetes [OR=1.24 (0.88-1.71), p=0.205] in logistic regression analyses.
CONCLUSIONS
In this study, GGT levels were associated with cardio-metabolic variables independent of HIV specific attributes. If confirmed in longitudinal studies, GGT evaluation maybe included in CVD risk monitoring strategies in people living with HIV.
Identifiants
pubmed: 33544719
doi: 10.1371/journal.pone.0246131
pii: PONE-D-20-26437
pmc: PMC7864415
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Cholesterol
97C5T2UQ7J
gamma-Glutamyltransferase
EC 2.3.2.2
gamma-glutamyltransferase, human
EC 2.3.2.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0246131Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2012;7(11):e48878
pubmed: 23145005
Clin Chem. 2003 Aug;49(8):1358-66
pubmed: 12881453
Nutrients. 2016 Jun 02;8(6):
pubmed: 27271659
Circulation. 2005 Oct 4;112(14):2130-7
pubmed: 16186419
Crit Rev Clin Lab Sci. 2001 Aug;38(4):263-355
pubmed: 11563810
J Am Soc Hypertens. 2015 Dec;9(12):951-8
pubmed: 26542414
J Hypertens. 2015 Dec;33(12):2373-81
pubmed: 26485462
Int J Epidemiol. 2012 Apr;41(2):433-45
pubmed: 22493325
BMC Infect Dis. 2020 Jul 3;20(1):473
pubmed: 32620082
Circ J. 2007 Oct;71(10):1567-72
pubmed: 17895553
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
N Engl J Med. 2007 Apr 26;356(17):1723-35
pubmed: 17460226
Clin Chem Lab Med. 2003 Sep;41(9):1191-8
pubmed: 14598869
Gut. 2005 Jan;54(1):122-7
pubmed: 15591516
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
J Hepatol. 2012 Nov;57(5):1083-9
pubmed: 22796154
Postgrad Med J. 2018 Nov;94(1117):641-646
pubmed: 30523069
Eur J Prev Cardiol. 2014 Dec;21(12):1541-8
pubmed: 23945039
Lancet. 2014 Sep 13;384(9947):1005-70
pubmed: 25059949
Diabetes Care. 2008 Jun;31(6):1138-43
pubmed: 18346992
J Infect Dis. 2012 Jun;205 Suppl 3:S362-7
pubmed: 22577209
J Atheroscler Thromb. 2011;18(3):177-81
pubmed: 21041983
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):565-76
pubmed: 26943980
Croat Med J. 2015 Feb;56(1):14-23
pubmed: 25727038
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Sci Rep. 2018 Feb 28;8(1):3764
pubmed: 29491346
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):127-33
pubmed: 17095717
J Clin Endocrinol Metab. 2004 Nov;89(11):5410-4
pubmed: 15531490
Clin Interv Aging. 2008;3(3):453-72
pubmed: 18982916
Circulation. 2008 Jul 8;118(2):198-210
pubmed: 18566320
Circulation. 2004 Mar 23;109(11):1440
pubmed: 15037540
Arch Cardiovasc Dis. 2015 Mar;108(3):206-15
pubmed: 25725995
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
BMC Infect Dis. 2017 Jan 7;17(1):41
pubmed: 28061822
Am J Epidemiol. 1994 Apr 15;139(8):787-92
pubmed: 7909980
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34
pubmed: 16878047
Diabetes Care. 2009 Apr;32(4):741-50
pubmed: 19131466
J Infect Dis. 2012 Jun;205 Suppl 3:S375-82
pubmed: 22577211
PLoS One. 2017 Sep 8;12(9):e0183029
pubmed: 28886047
Atherosclerosis. 2017 Oct;265:102-109
pubmed: 28881267